# A Dose Increase Finding Study of Doxorubicin Hydrochloride Liposome Injection for Patients With Breast Cancer

> **NCT03017404** · NA · COMPLETED · sponsor: **Hebei Medical University Fourth Hospital** · enrollment: 18 (actual)

## Conditions studied

- Breast Cancer

## Interventions

- **DRUG:** Doxorubicin Hydrochloride Liposome Injection
- **DRUG:** Cyclophosphamide
- **DRUG:** docetaxel

## Key facts

- **NCT ID:** NCT03017404
- **Lead sponsor:** Hebei Medical University Fourth Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-05
- **Primary completion:** 2016-05
- **Final completion:** 2016-07
- **Target enrollment:** 18 (ACTUAL)
- **Last updated:** 2017-01-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03017404

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03017404, "A Dose Increase Finding Study of Doxorubicin Hydrochloride Liposome Injection for Patients With Breast Cancer". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT03017404. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*